ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

Study of SIR-Spheres Plus Sorafenib as 1st Line Treatment for Non-resectable Primary Hepatocellular Carcinoma (HCC)

Singapore Clinical Research Institute · 2008
ClinicalTrials.gov · Datasets · License: Public Domain · 2008
Open Source ↗
hepatocellular-carcinoma
hepatocellular carcinoma, first line treatment for hepatocellular carcinoma, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 906619
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.